Principal Investigator
Mark Jara
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241335
Clinical Trial Summary
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to
Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as
Treatment for Adult Patients With Graves' Disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other